Clinical Study on Bosentan in Treatment of Idiopathic Pulmonary Arterial Hypertension

Objective To observe the efficacy of Bosentan in idiopathic pulmonary hypertension(IPAH).Methods 15 patients with IPAH were treated with Bosentan,to compare the changes of indicator.Results After treatment,the patients’ cardiac function has been significantly improved,and other indicators had been improved significantly(P0.05).Conclusion Bosentan is safe and effective in treatment of IPAH,and it is worthy of clinical recommendations.